ZA882080B - Substituted benzazepines,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted benzazepines,their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA882080B
ZA882080B ZA882080A ZA882080A ZA882080B ZA 882080 B ZA882080 B ZA 882080B ZA 882080 A ZA882080 A ZA 882080A ZA 882080 A ZA882080 A ZA 882080A ZA 882080 B ZA882080 B ZA 882080B
Authority
ZA
South Africa
Prior art keywords
alkyl
preparation
pharmaceutical compositions
alkoxyalkyl
cycloalkyl
Prior art date
Application number
ZA882080A
Other languages
English (en)
Inventor
Joel Gidbert Berger
Gidbert Berger Joel
Wei Kong Chang
Kong Chang Wei
Marjorie Peters
Peters Marjorie
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA882080B publication Critical patent/ZA882080B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA882080A 1987-03-27 1988-03-23 Substituted benzazepines,their preparation and pharmaceutical compositions containing them ZA882080B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3213587A 1987-03-27 1987-03-27

Publications (1)

Publication Number Publication Date
ZA882080B true ZA882080B (en) 1989-04-26

Family

ID=21863286

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882080A ZA882080B (en) 1987-03-27 1988-03-23 Substituted benzazepines,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (2) EP0285919B1 (da)
JP (1) JPH0662574B2 (da)
KR (1) KR930011489B1 (da)
AT (1) ATE112766T1 (da)
AU (1) AU619744B2 (da)
CA (1) CA1321195C (da)
DE (1) DE3851769T2 (da)
DK (1) DK165688C (da)
FI (1) FI894566A (da)
HU (1) HU205744B (da)
IL (1) IL85855A (da)
MY (1) MY103357A (da)
NO (1) NO174507B (da)
NZ (1) NZ224038A (da)
PH (1) PH27337A (da)
PT (1) PT87068B (da)
WO (1) WO1988007526A1 (da)
ZA (1) ZA882080B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
AU8201591A (en) * 1990-06-15 1992-01-07 Schering Corporation 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them
US5374722A (en) * 1990-09-25 1994-12-20 Schering Corporation Bridged benzazepines
US5241065A (en) * 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
EP1307430B1 (en) * 2000-07-05 2005-09-28 Ortho-McNeil Pharmaceutical, Inc. Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
RU2423353C1 (ru) * 2002-12-20 2011-07-10 Глэксо Груп Лимитед Новые производные бензазепина
JP2006526021A (ja) 2003-05-22 2006-11-16 シェーリング コーポレイション 肥満およびcns障害を治療する選択的d1/d5レセプタアンタゴニストとしての5h−ベンゾ[d]ナフト[2,1−b]アゼピン誘導体
EP2332920A3 (en) * 2003-06-17 2011-12-21 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
AU2012200805B2 (en) * 2003-06-17 2015-01-22 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
PL2332921T3 (pl) 2003-06-17 2016-08-31 Arena Pharm Inc Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
CN101084193B (zh) 2004-12-21 2011-12-07 艾尼纳制药公司 (r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓盐酸盐的晶型
SG158168A1 (en) 2004-12-23 2010-01-29 Arena Pharm Inc 5ht2c receptor modulator compositions and methods of use
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
ES2522587T3 (es) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
EP2611449A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
UY34436A (es) 2012-10-09 2014-07-31 Arena Pharm Inc Metodo de control del peso
HU230826B1 (hu) 2014-11-19 2018-07-30 Richter Gedeon Nyrt. Eljárás benzazepin származékok előállítására

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
DE1934150A1 (de) * 1968-07-10 1970-01-15 Pennwalt Corp Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine
US4988690A (en) * 1982-06-14 1991-01-29 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof

Also Published As

Publication number Publication date
DK652688A (da) 1988-11-23
PT87068B (pt) 1992-07-31
JPH0662574B2 (ja) 1994-08-17
DE3851769D1 (de) 1994-11-17
EP0357641A1 (en) 1990-03-14
AU619744B2 (en) 1992-02-06
NZ224038A (en) 1990-10-26
NO174507B (no) 1994-02-07
NO174507C (da) 1994-05-18
HUT53882A (en) 1990-12-28
EP0285919A1 (en) 1988-10-12
DK652688D0 (da) 1988-11-23
CA1321195C (en) 1993-08-10
IL85855A0 (en) 1988-09-30
KR890700577A (ko) 1989-04-25
DE3851769T2 (de) 1995-03-09
DK165688C (da) 1993-05-24
AU1596488A (en) 1988-11-02
DK165688B (da) 1993-01-04
JPH02502723A (ja) 1990-08-30
IL85855A (en) 1993-02-21
NO885096D0 (no) 1988-11-15
EP0285919B1 (en) 1994-10-12
HU205744B (en) 1992-06-29
KR930011489B1 (ko) 1993-12-08
PH27337A (en) 1993-06-08
ATE112766T1 (de) 1994-10-15
MY103357A (en) 1993-06-30
PT87068A (pt) 1988-04-01
NO885096L (no) 1988-11-15
WO1988007526A1 (en) 1988-10-06
FI894566A0 (fi) 1989-09-27
FI894566A (fi) 1989-09-27

Similar Documents

Publication Publication Date Title
ZA882080B (en) Substituted benzazepines,their preparation and pharmaceutical compositions containing them
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
HUT68762A (en) Fungicidal composition containing carboxyanilide and process for their preparation
HUT62296A (en) Herbicidal composition comprising hydantoin derivative as active ingredient and process for producing the active ingredient
AU1832988A (en) Thiazole derivatives
DE3873578T2 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
EP1147772A4 (en) DRUG COMPOSITIONS FOR THE TREATMENT OF EAR FIBRILLATION
GR3003966T3 (da)
GB8925032D0 (en) Chemical compounds
DE3671012D1 (de) 5-alkylsulfonylsalicylanilide und mikrobizide zusammensetzungen fuer die regulierung des wachstums von mikroorganismen.
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
DE69309461D1 (de) Zusammensetzung zur Beschleunigung der Wundheilung
ZA918518B (en) 8-azabicyclo(3.2.1)octylalkylthiazolidinones,a process for their preparation and their use as medicaments
PT84367A (en) Process for the preparation of a fungicidal compound containing a naphthimidezolone
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
HUT59083A (en) Improved process for producing 4-methyl-sulfonyl-benzoic acid derivatives
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
WO1999050252A3 (en) Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
ES8307831A1 (es) Procedimiento para preparar nuevos derivados organofosfora- dos.
HUT53890A (en) Fungicides comprising o-(1,2,4-triazol-1-yl)-o-phenylacetate derivatives as active ingredient and process for producing the active ingredients
DE69129605T2 (de) Verfahren zur Herstellung von N-Alkylpyrazolen
MY103596A (en) Insecticidal compounds - characterised by enhanced knockdown effect.